TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 2 | 1 | -1 | 159 | 889 | 651 | 284 |
| S | %wins | 33 | 67 | 67 | 50 | 50 | 0 | 44 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/16/17 17:09 | 2/14/17 | EBIO | Eleven Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McCabe John J | MA | O | CFO | S | -3 | 2.10 | 1 | -1 | -19 | 6 | D | -80 | 614 | -62 | -29 | -10 | 0 | -12 | -4 | 2 | 0 | -8 | |||
8/17/16 07:07 | 8/15/16 | EBIO | Eleven Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McCabe John J | MA | O | CFO | S | -6 | 4.80 | 18 | -1 | -14 | 7 | D | -55 | 34 | 999 | 392 | 167 | 37 | 33 | 34 | -5 | -4 | -28 | -46 | -62 | |
2/17/16 17:04 | 2/16/16 | EBIO | Eleven Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McCabe John J | MA | O | SVP,Fina | S | 0 | 0.2700 | 0 | -2 | -15 | 8 | D | -98 | -97 | -94 | -90 | -90 | -21 | -8 | 1 | 8 | 7 | 34 | 364 | 999 | 651 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |